Detalhe da pesquisa
1.
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.
N Engl J Med
; 382(14): 1331-1342, 2020 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32242358
2.
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results.
Blood
; 138(1): 11-22, 2021 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33827116
3.
A phase I study of the vitamin D3 analogue ILX23-7553 administered orally to patients with advanced solid tumors.
Invest New Drugs
; 29(6): 1420-5, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20661623
4.
Prevalence of hypercalcemia among cancer patients in the United States.
Cancer Med
; 5(8): 2091-100, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27263488
5.
Recent Progress and Advances in HGF/MET-Targeted Therapeutic Agents for Cancer Treatment.
Biomedicines
; 3(1): 149-181, 2015 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28536405
6.
Novel phase I study combining G1 phase, S phase, and G2/M phase cell cycle inhibitors in patients with advanced malignancies.
Cell Cycle
; 14(21): 3434-40, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26467427
7.
Denosumab for treatment of hypercalcemia of malignancy.
J Clin Endocrinol Metab
; 99(9): 3144-52, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24915117
8.
Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment.
J Natl Cancer Inst
; 105(18): 1417-20, 2013 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23990665
9.
Change in tumor size by RECIST correlates linearly with overall survival in phase I oncology studies.
J Clin Oncol
; 30(21): 2684-90, 2012 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22689801
10.
GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.
Clin Cancer Res
; 17(22): 7174-82, 2011 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21933889
11.
Food and oral antineoplastics: more than meets the eye.
Clin Cancer Res
; 16(17): 4305-7, 2010 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20736331
12.
Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worse.
Clin Cancer Res
; 16(4): 1289-97, 2010 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20145187
14.
RE: Meta-analysis of the relationship between dose and benefit in phase I targeted agent trials.
J Natl Cancer Inst
; 105(11): 833, 2013 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23628598
15.
Reply to A. Levy et al.
J Clin Oncol
; 31(3): 396, 2013 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23451354
16.
Local complexity of amino acid interactions in a protein core.
Proc Natl Acad Sci U S A
; 101(1): 111-6, 2004 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-14684834